yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58713722-0A37415A-63CD-499E-8E21-89EAE9E1F30E
Q58713722-0A37415A-63CD-499E-8E21-89EAE9E1F30E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58713722-0A37415A-63CD-499E-8E21-89EAE9E1F30E
Centronuclear myopathies under attack: A plethora of therapeutic targets
P2860
Q58713722-0A37415A-63CD-499E-8E21-89EAE9E1F30E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58713722-0A37415A-63CD-499E-8E21-89EAE9E1F30E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b4d50a69091c4b8b8a9f6b0f5c77622908c615c
P2860
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.